Azenta, Inc. (AZTA) · Insider trading
What Azenta's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$171,897
2 insiders, 2 trades
Sold, 12 months
$0
0 insiders
Net, 12 months
+$171,897
bought less sold
Latest filing
2026-09-23
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Cornog William LDirector | $848,684 | – | 5 | 2026-05-18 | – |
| Marotta JohnDirector, President and CEO | $578,894 | $9,294 | 4 | 2025-09-10 | 105,980 |
| Malus Alan JDirector | $319,800 | – | 1 | 2025-05-30 | 17,035 |
| Madaus Martin DDirector | $201,404 | – | 1 | 2024-11-19 | 7,405 |
| Lin Lawrence Y.EVP, CFO and Treasurer | $69,900 | – | 1 | 2025-08-11 | 46,013 |
| Zhou GingerSVP and GM, Multiomics | $19,132 | $50,640 | 3 | 2025-08-12 | 26,831 |
| Pirogova OlgaSVP and CHRO | – | $52,924 | 2 | 2025-08-12 | 18,288 |
| Joseph JasonSVP, General Counsel, Secy. | – | $45,640 | 1 | 2024-11-19 | 112,564 |
| Hirsch DidierDirector | $39,500 | – | 1 | 2024-11-18 | 3,465 |
| Cueto HermanEVP, Chief Financial Officer | – | $28,530 | 1 | 2024-11-19 | 23,892 |
| Hughes ViolettaVP, Chief Accounting Officer | – | $23,323 | 2 | 2025-02-03 | 9,603 |
| Wang David DongSVP & GM, SMS | – | $13,944 | 1 | 2024-11-19 | 24,114 |
| Starr EphraimSVP, Gen Counsel & Secretary | $8,097 | – | 1 | 2026-07-31 | 68,728 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-31 | Starr EphraimSVP, Gen Counsel & Secretary | Buy | 335 | 24.17 | $8,097 | 68,728 | Form 4 |
| 2026-05-18 | Cornog William LDirector | Buyindirect | 10,000 | 16.38 | $163,800 | 19,703 | Form 4 |
| 2025-09-10 | Marotta JohnDirector, President and CEO | Sale | 316 | 29.41 | $9,294 | 105,980 | Form 4 |
| 2025-08-12 | Zhou GingerSVP and GM, Multiomics | Sale | 1,085 | 28.54 | $30,966 | 26,831 | Form 4/A |
| 2025-08-12 | Pirogova OlgaSVP and CHRO | Sale | 1,085 | 28.54 | $30,966 | 18,288 | Form 4/A |
| 2025-08-11 | Lin Lawrence Y.EVP, CFO and Treasurer | Buy | 2,500 | 27.96 | $69,900 | 46,013 | Form 4 |
| 2025-06-02 | Marotta JohnDirector, President and CEO | Buy | 1,000 | 25.99 | $25,990 | 107,296 | Form 4/A |
| 2025-05-30 | Malus Alan JDirector | Buy | 12,000 | 26.65 | $319,800 | 17,035 | Form 4/A |
| 2025-05-20 | Cornog William LDirector | Buy | 2,748 | 27.37 | $75,213 | 25,795 | Form 4/A |
| 2025-05-19 | Cornog William LDirector | Buy | 4,152 | 26.98 | $112,021 | 23,047 | Form 4/A |
| 2025-05-16 | Cornog William LDirector | Buy | 100 | 26.50 | $2,650 | 18,895 | Form 4/A |
| 2025-02-03 | Hughes ViolettaVP, Chief Accounting Officer | Sale | 317 | 52.97 | $16,791 | 9,603 | Form 4 |
| 2025-01-31 | Zhou GingerSVP and General Manager, Genom | Buy | 417 | 45.88 | $19,132 | 27,916 | Form 4 |
| 2024-11-19 | Cueto HermanEVP, Chief Financial Officer | Sale | 712 | 40.07 | $28,530 | 23,892 | Form 4 |
| 2024-11-19 | Joseph JasonSVP, General Counsel, Secy. | Sale | 1,139 | 40.07 | $45,640 | 112,564 | Form 4 |
| 2024-11-19 | Wang David DongSVP & GM, SMS | Sale | 348 | 40.07 | $13,944 | 24,114 | Form 4 |
| 2024-11-19 | Zhou GingerSVP and General Manager, Genom | Sale | 491 | 40.07 | $19,674 | 27,499 | Form 4 |
| 2024-11-19 | Hughes ViolettaVP, Chief Accounting Officer | Sale | 163 | 40.07 | $6,531 | 9,920 | Form 4 |
| 2024-11-19 | Pirogova OlgaSVP and CHRO | Sale | 548 | 40.07 | $21,958 | 19,373 | Form 4 |
| 2024-11-19 | Madaus Martin DDirector | Buy | 4,940 | 40.77 | $201,404 | 7,405 | Form 4 |
| 2024-11-19 | Marotta JohnDirector, President and CEO | Buy | 1,250 | 40.67 | $50,838 | 100,862 | Form 4 |
| 2024-11-18 | Cornog William LDirector | Buyindirect | 12,500 | 39.60 | $495,000 | 14,755 | Form 4 |
| 2024-11-18 | Hirsch DidierDirector | Buy | 1,000 | 39.50 | $39,500 | 3,465 | Form 4 |
| 2024-11-18 | Marotta JohnDirector, President and CEO | Buy | 12,717 | 39.48 | $502,066 | 99,612 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
44 × grant or award7 × shares withheld for tax5 × returned to the company
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-22 | Madaus Martin DInterim CEO | Shares withheld for tax F | −1,456 | 34.28 | 42,602 | Form 4 |
| 2026-09-15 | Bello Erik J.VP Chief Accounting Officer | Grant or award A | +4,586 | – | 4,586 | Form 4 |
| 2026-09-14 | Starr EphraimSVP, Gen Counsel & Secretary | Grant or award A | +15,272 | – | 84,000 | Form 4 |
| 2026-09-14 | Lin Lawrence Y.EVP, CFO and Treasurer | Grant or award A | +30,544 | – | 110,199 | Form 4 |
| 2026-09-14 | Pirogova OlgaSVP and CHRO | Grant or award A | +15,272 | – | 47,225 | Form 4 |
| 2026-09-14 | Martin William e. IIIPresident Multiomics | Grant or award A | +15,272 | – | 33,062 | Form 4 |
| 2026-09-14 | Madaus Martin DInterim CEO | Grant or award A | +36,653 | – | 44,058 | Form 4 |
| 2026-08-09 | Pirogova OlgaSVP and CHRO | Shares withheld for tax F | −1,085 | 32.04 | 31,953 | Form 4 |
| 2026-05-15 | Starr EphraimSVP, Gen Counsel & Secretary | Shares withheld for tax F | −3,621 | 16.02 | 68,393 | Form 4 |
| 2026-04-28 | Martin William e. IIIPresident Multiomics | Grant or award A | +17,790 | 24.24 | 17,790 | Form 4 |
| 2026-02-06 | Nova Tina SusanDirector | Grant or award A | +5,663 | 27.85 | 15,772 | Form 4 |
| 2026-02-05 | Koffey QuentinDirector | Grant or award A | +5,663 | – | 10,698 | Form 4 |
| 2026-02-05 | McLaughlin EricaDirector | Grant or award A | +5,663 | 27.85 | 22,521 | Form 4 |
| 2026-02-05 | Casal FrankDirector | Grant or award A | +7,243 | 27.85 | 21,803 | Form 4 |
| 2026-02-05 | Doshi DipalDirector | Grant or award A | +5,663 | 27.85 | 9,703 | Form 4 |
| 2025-11-24 | Marotta JohnDirector, President and CEO | Grant or award A | +118,194 | – | 213,194 | Form 4/A |
| 2025-11-24 | Starr EphraimSVP, Gen Counsel & Secretary | Grant or award A | +34,235 | – | 72,014 | Form 4 |
| 2025-11-24 | Zhou GingerSVP and GM, Multiomics | Grant or award A | +13,042 | – | 38,755 | Form 4 |
| 2025-11-24 | Pirogova OlgaSVP and CHRO | Grant or award A | +16,303 | – | 33,038 | Form 4 |
| 2025-11-24 | Lin Lawrence Y.EVP, CFO and Treasurer | Grant or award A | +36,681 | – | 79,655 | Form 4 |
| 2025-11-14 | Marotta JohnDirector, President and CEO | Shares withheld for tax F | −10,980 | 29.75 | 95,000 | Form 4 |
| 2025-11-14 | Lin Lawrence Y.EVP, CFO and Treasurer | Shares withheld for tax F | −3,039 | 29.75 | 42,974 | Form 4 |
| 2025-11-14 | Pirogova OlgaSVP and CHRO | Shares withheld for tax F | −1,553 | 29.75 | 16,735 | Form 4 |
| 2025-11-14 | Zhou GingerSVP and GM, Multiomics | Shares withheld for tax F | −1,118 | 29.75 | 25,713 | Form 4 |
| 2025-08-12 | Pirogova OlgaSVP and CHRO | Returned to the company D | −1,085 | 28.54 | 18,288 | Form 4 |
| 2025-08-12 | Zhou GingerSVP and GM, Multiomics | Returned to the company D | −1,085 | 28.54 | 26,831 | Form 4 |
| 2025-06-02 | Marotta JohnDirector, President and CEO | Grant or award A | +1,000 | 25.99 | 107,296 | Form 4 |
| 2025-05-30 | Malus Alan JDirector | Grant or award A | +12,000 | 26.65 | 17,035 | Form 4 |
| 2025-05-20 | Cornog William LDirector | Grant or award A | +2,748 | 27.37 | 21,755 | Form 4 |
| 2025-05-19 | Cornog William LDirector | Grant or award A | +4,152 | 26.98 | 19,007 | Form 4 |
| 2025-05-16 | Cornog William LDirector | Grant or award A | +100 | 26.50 | 14,855 | Form 4 |
| 2025-05-15 | Starr EphraimSVP, Gen Counsel & Secretary | Grant or award A | +37,779 | 26.71 | 37,779 | Form 4 |
| 2025-05-09 | Marotta JohnDirector, President and CEO | Grant or award A | +1,796 | 27.49 | 106,296 | Form 4/A |
| 2025-05-09 | Lin Lawrence Y.EVP, CFO and Treasurer | Grant or award A | +4,000 | 27.49 | 43,513 | Form 4 |
| 2025-05-08 | Marotta JohnDirector, President and CEO | Grant or award A | +3,638 | 27.49 | 104,500 | Form 4/A |
| 2025-05-08 | Lin Lawrence Y.EVP, CFO and Treasurer | Grant or award A | +2,000 | 27.67 | 39,513 | Form 4 |
| 2025-02-11 | Lin Lawrence Y.EVP, CFO and Treasurer | Grant or award A | +2,200 | 46.00 | 37,513 | Form 4 |
| 2025-02-07 | McLaughlin EricaDirector | Grant or award A | +4,040 | 52.32 | 16,858 | Form 4 |
| 2025-02-07 | Doshi DipalDirector | Grant or award A | +4,040 | 52.32 | 4,040 | Form 4 |
| 2025-02-07 | Nova Tina SusanDirector | Grant or award A | +4,040 | 52.32 | 10,109 | Form 4 |
| 2025-02-07 | Davis Robyn CDirector | Grant or award A | +4,040 | 52.32 | 33,627 | Form 4 |
| 2025-02-07 | Casal FrankDirector | Grant or award A | +5,168 | 52.32 | 14,560 | Form 4 |
| 2025-02-07 | Malus Alan JDirector | Grant or award A | +4,040 | 52.32 | 5,035 | Form 4 |
| 2025-02-07 | Koffey QuentinDirector | Grant or award A | +4,040 | – | 5,035 | Form 4 |
| 2024-12-05 | Lin Lawrence Y.EVP, CFO and Treasurer | Grant or award A | +23,045 | 45.00 | 29,545 | Form 4 |
| 2024-12-05 | Lin Lawrence Y.EVP, CFO and Treasurer | Grant or award A | +5,768 | 45.00 | 35,313 | Form 4 |
| 2024-12-04 | Wang David DongSVP & GM, SMS | Returned to the company D | −140 | 46.65 | 23,974 | Form 4 |
| 2024-11-15 | Zhou GingerSVP and General Manager, Genom | Grant or award A | +8,651 | 41.51 | 27,990 | Form 4 |
| 2024-11-15 | Wang David DongSVP & GM, SMS | Grant or award A | +8,651 | 41.51 | 24,462 | Form 4 |
| 2024-11-15 | Hughes ViolettaVP, Chief Accounting Officer | Grant or award A | +6,921 | 41.51 | 10,083 | Form 4 |
| 2024-11-15 | Joseph JasonSVP, General Counsel, Secy. | Grant or award A | +13,841 | 41.51 | 113,703 | Form 4 |
| 2024-11-15 | Marotta JohnDirector, President and CEO | Grant or award A | +83,622 | 41.51 | 86,895 | Form 4 |
| 2024-11-15 | Pirogova OlgaSVP and CHRO | Grant or award A | +10,381 | 41.51 | 19,921 | Form 4 |
| 2024-11-06 | Malus Alan JDirector | Returned to the company D | +995 | 46.52 | 995 | Form 4 |
| 2024-11-06 | Cornog William LDirector | Returned to the company D | −995 | 46.52 | 2,255 | Form 4 |
| 2024-11-06 | Koffey QuentinDirector | Grant or award A | +995 | – | 995 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.